Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Laberge

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21Andrea Bezjak, Dongsheng Tu, Lesley Seymour, et al.
BMJ Open|January 20, 2019
Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohortNiloofar Taghizadeh, Alain Tremblay, Sonya Cressman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 studyGlenwood D Goss, Andrew Arnold, Frances A Shepherd, et al.
The European Respiratory Journal|January 24, 2015
Plasma pro-surfactant protein B and lung function decline in smokersJanice M Leung, John Mayo, Wan Tan, et al.
Chest|May 5, 2016
Low Prevalence of High-Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening StudyAlain Tremblay, Niloofar Taghizadeh, Annette M McWilliams, et al.
The New England Journal of Medicine|September 6, 2013
Probability of cancer in pulmonary nodules detected on first screening CTAnnette McWilliams, Martin C Tammemagi, John R Mayo, et al.
The Lancet. Oncology|October 23, 2017
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective studyMartin C Tammemagi, Heidi Schmidt, Simon Martel, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21Andrea Bezjak, Dongsheng Tu, Lesley Seymour, et al.
BMJ Open|January 20, 2019
Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohortNiloofar Taghizadeh, Alain Tremblay, Sonya Cressman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 studyGlenwood D Goss, Andrew Arnold, Frances A Shepherd, et al.
The European Respiratory Journal|January 24, 2015
Plasma pro-surfactant protein B and lung function decline in smokersJanice M Leung, John Mayo, Wan Tan, et al.
Chest|May 5, 2016
Low Prevalence of High-Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening StudyAlain Tremblay, Niloofar Taghizadeh, Annette M McWilliams, et al.
The New England Journal of Medicine|September 6, 2013
Probability of cancer in pulmonary nodules detected on first screening CTAnnette McWilliams, Martin C Tammemagi, John R Mayo, et al.
The Lancet. Oncology|October 23, 2017
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective studyMartin C Tammemagi, Heidi Schmidt, Simon Martel, et al.
Pageof 2